关于控股股东及一致行动人协议转让股份进展情况的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603330 证券简称：天洋新材 公告编号：2025-054 天洋新材（上海）科技股份有限公司 具体内容详见公司2025年4月9日于上海证券交易所网站（www.sse.com.cn）及上海证券报上披露的《关 于控股股东、实际控制人签署〈股份转让协议〉〈表决权放弃协议〉暨控制权拟变更的提示性公告》 （公告编号：2025-022）；2025年4月10日于上海证券交易所网站（www.sse.com.cn）及上海证券报上 披露的《天洋新材（上海）科技股份有限公司简式权益变动报告书（转让方）》（公告编号：2025- 023）和《天洋新材（上海）科技股份有限公司详式权益变动报告书（受让方）》（公告编号：2025- 024）。 二、协议转让进展情况 截至目前，本次股份协议转让尚未完成过户。本次协议转让股份事项已于2025年5月13日经上海证券交 易所合规性审核确认，并于20 ...

本次权益变动属于股份协议转让，不涉及要约收购，不会导致公司控股股东及实际控制人发生变化，不 会对公司持续稳定经营产生不利影响。 2024年1至12月份，国邦医药的营业收入构成为：医药板块占比64.87%，动物保健品板块占比34.24%， 其他占比0.48%，其他业务占比0.4%。 本次股权转让完成后，国有运营公司拟支持公司在医药领域的全面发展，在产业链协同、新业务培育、 资本运作等领域积极开展战略合作，协同公司进一步做大做强。在符合国有运营公司投资标准和要求的 前提下，国有运营公司重点支持公司主营业务相关领域的投入，双方拟在未来的合作过程中加强人员交 流，在投资项目研判、新技术论证、场景应用、智库咨询等方面开展协同赋能。具体合作内容和进度将 根据双方后续工作进一步落实和推进，尚需双方根据实际情况共同协商确定后另行签署合作协议，存在 不确定性。公司将根据规则要求及相关进展及时履行信息披露义务。敬请广大投资者注意投资风险。 国邦医药（SH 605507，收盘价：23.07元）8月20日晚间发布公告称，基于公司战略发展需要，引入看 好公司价值和看好公司未来发展的战略投资者，共同推动医药产业的创新发展，国邦医药集团股 ...

Core Viewpoint - The announcement details a share transfer agreement where Xingye Investment will transfer 32 million unrestricted circulating shares of Xinghui Co., accounting for 6.99% of the total share capital, to Wang Xiaodong at a price of 4.5 RMB per share, totaling 144 million RMB [1] Group 1 - Xingye Investment will transfer 32 million shares at a price of 4.5 RMB per share [1] - The total transaction value amounts to 144 million RMB [1] - After the transfer, Wang Xiaodong will hold 6.99% of the company's total shares, becoming a shareholder with over 5% ownership [1] Group 2 - Wang Xiaodong has committed to not reducing his shareholding within 12 months [1] - The transfer is subject to compliance review by Shenzhen Stock Exchange [1] - The share transfer will require registration with China Securities Depository and Clearing Corporation Limited, Shenzhen Branch [1]

Core Viewpoint - The report outlines the equity transfer agreements involving Chengdu Hongqi Chain Co., Ltd, highlighting the change in control to Sichuan Provincial State-owned Assets Supervision and Administration Commission through the acquisition by Sichuan Shengtong Investment Co., Ltd [2][4]. Group 1: Equity Transfer Details - Sichuan Shengtong Investment Co., Ltd will acquire a total of 93,925,000 shares from Cao Shiru and Cao Zengjun, representing 6.91% of the total share capital of Hongqi Chain [2]. - After the transfer, Cao Shiru will hold 245,565,000 shares (18.06%), Cao Zengjun will hold 36,210,000 shares (2.66%), and Sichuan Shengtong Investment will hold 229,925,000 shares (16.91%) [3]. - The total number of voting shares after the transfer will be 1,078,225,000, with Sichuan Shengtong controlling 21.32% of the voting rights [4]. Group 2: Regulatory Compliance and Oversight - The financial advisor, Huaxi Securities, will provide continuous supervision for 12 months following the completion of the equity transfer, ensuring compliance with relevant laws and regulations [4]. - The report confirms that during the supervision period, both the acquirer and Hongqi Chain have adhered to legal and regulatory requirements [8][12]. - There are no plans to change the main business operations or make significant adjustments to the company’s structure within the next 12 months [9][12]. Group 3: Future Commitments and Governance - The acquirer has committed to maintaining the independence of the listed company and avoiding competition with related parties [8]. - The governance structure will include a board of directors composed of 9 members, with the acquirer entitled to nominate 4 non-independent directors and 3 independent directors [10]. - There are no plans to modify the company’s articles of association or employee hiring policies in the near future [11][12].

中国经济网北京8月18日讯雅创电子（301099）(301099.SZ)8月15日披露公告，公司股东盐城硕卿企业管理中心(有限合伙)(以下简称"硕卿合伙")拟转让股份 6,980,000股，占雅创电子总股本的比例为4.76%，占已剔除回购专用账户中股份数量的总股本比例为4.96%。 本次询价转让出让方硕卿合伙为公司控股股东、实际控制人谢力书担任执行事务合伙人的员工持股平台，系公司控股股东、实际控制人的一致行动人；同 时，公司部分董事通过硕卿合伙间接持有公司股份。出让方硕卿合伙持有公司股本比例超过5%。 本次询价转让不通过集中竞价交易或大宗交易方式进行，不属于通过二级市场减持，受让方通过询价转让受让的股份，在受让后6个月内不得转让。本次询 价转让的受让方为具备相应定价能力和风险承受能力的机构投资者。硕卿合伙委托国信证券股份有限公司(以下简称"国信证券")组织实施雅创电子首发前股 东询价转让。 | 拟转让股 东名称 | 拟转让股份 数量(股) | 占总股本 比例 | 占已剔除回购专 用账户中股数的 | 占所持股份比例 (截至 2025 年 8 | 转让原因 | | --- | --- | --- | --- | ...

Core Viewpoint - The financial advisor, Huatai United Securities, has conducted a thorough review of the equity change report for Shanghai Swancor New Materials Technology Co., Ltd., confirming the authenticity, accuracy, and completeness of the disclosed information [2][13][14]. Summary by Sections Financial Advisor's Review - The financial advisor asserts that the information provided by the disclosing party is true, accurate, and complete, with no false records or misleading statements found [2][13]. - The advisor has fulfilled its due diligence obligations and believes there are no substantial discrepancies between its professional opinions and the disclosed documents [2][3]. Equity Change Details - The equity change involves Shanghai Zhiyuan Hengyue Technology Partnership acquiring 100,800,016 shares from Swancor Samoa, representing 24.99% of the total shares of the listed company [7][9]. - Additionally, Zhiyuan Hengyue plans to further increase its stake through a partial tender offer for 149,243,840 shares, which accounts for 37.00% of the total share capital [10][15]. Purpose of the Equity Change - The purpose of the equity change is to gain control of the listed company, with a focus on sustainable development and enhancing shareholder value, particularly for minority shareholders [14][15]. - The advisor has communicated with the disclosing party regarding the purpose of the equity change, finding it reasonable and compliant with current laws and regulations [15]. Future Plans - The disclosing party intends to continue increasing its shareholding within the next 12 months, with plans to acquire additional shares through a tender offer [15][16]. - The advisor confirms that the funds for the equity change will come from the disclosing party's own and self-raised funds, with no financial assistance from the listed company or its affiliates [25][31]. Lock-up Commitments - The disclosing party has made commitments regarding the lock-up of shares acquired during the transaction, agreeing not to transfer these shares for 36 months following the completion of the acquisition [17][18].

Group 1 - The company announced that shareholders Hainan Yuminghua Venture Capital Co., Ltd. and Mr. Chen Yaomin have completed the transfer of 9.3343 million shares [1] - After the transfer, Mr. Chen Yaomin holds 52.0328 million shares, accounting for 28.28% of the total share capital, making him a shareholder with more than 5% ownership [1] - This transfer further consolidates the control of Xingkong Technology and its concerted parties over the company, and will not lead to changes in the controlling shareholder or actual controller [1]

股票代码：001234 股票简称：泰慕士 公告编号：2025-045 江苏泰慕士针纺科技股份有限公司 关于控股股东签署《股份转让协议》等相关协议 "上市公司"）控股股东如皋新泰投资有限公司（以下简称"新泰投资"） 股东南通泰达股权投资合伙企业(有限合伙)（以下简称"泰达投资"）、南通泰然 股权投资合伙企业(有限合伙)（以下简称"泰然投资"）、实际控制人陆彪先生、 杨敏女士与广州轻工工贸集团有限公司（以下简称"广州轻工集团"）签署了《股 份转让协议》，新泰投资拟向广州轻工集团转让其持有上市公司无限售条件流通 股 32,813,168 股，占上市公司总股本的 29.99%。同时，控股股东新泰投资、股 东泰达投资、泰然投资放弃其合法持有的上市公司合计 23,186,832 股股份（约 占上市公司总股本的 21.19%）对应的表决权。若本次股份转让事项实施并完成， 公司的控股股东及实际控制人将发生变更。广州轻工集团将成为公司控股股东， 广州市国资委将成为公司实际控制人。 的合规性确认意见并在中国证券登记结算公司深圳分公司办理股份过户登记手 续以及完成相关法律法规要求可能涉及的其他批准，该事项能否最终实施完成 及实施结 ...

Core Viewpoint - The stock of Heizhima resumed trading on August 11, showing a price increase of 3.98% to 6.8 yuan per share, with a total market capitalization of approximately 5.124 billion yuan [1]. Group 1: Shareholder Changes - Heizhima's controlling shareholder, Guangxi Heiwulei Food Group Co., Ltd. (referred to as "Heiwulei Group"), is planning to transfer its shares [1]. - Heiwulei Group has signed a share transfer agreement with Guangxi Lvfa Big Health Industry Group Co., Ltd. (referred to as "Lvfa Big Health"), which intends to acquire 20% of Heizhima's shares [1]. - Following the completion of the share transfer, the controlling shareholder of Heizhima will change from Heiwulei Group to Lvfa Big Health, and the actual controller will shift to the Guangxi State-owned Assets Supervision and Administration Commission [1]. Group 2: Shareholding Structure - Heiwulei Group currently holds approximately 228 million shares of Heizhima, accounting for 30.25% of the total share capital [2]. - Out of the shares held by Heiwulei Group, about 162 million shares (21.51% of the total shares) are under pledge, which may affect the transfer process [2]. - If the pledged shares do not meet the delivery conditions in a timely manner, there could be a risk of non-delivery [2].

Core Viewpoint - Bidet Technology (605298.SH) announced a share transfer agreement involving its actual controllers and their concerted actors, which will not change the control of the company [1][2]. Share Transfer Details - The actual controllers Wang Jianqun, Liu Ying, and their concerted actors Wang Kai, Wang Jianping, and Li Biyu will transfer a total of 56,167,150 shares, representing 29.90% of the company's total share capital, to Yangzhou Dinglong Qishun Equity Investment Partnership (Limited Partnership) for a total price of 897 million yuan, at a price of 15.97 yuan per share [1][2]. - Before the transfer, the shareholdings of the controllers were 97,344,000 shares (51.82%), 34,058,482 shares (18.13%), 1,571,700 shares (0.84%), 771,479 shares (0.41%), and 405,600 shares (0.22%) respectively [1][2]. Post-Transfer Shareholding Structure - After the transfer, Wang Jianqun and Liu Ying will hold 73,008,000 shares (38.87%) and 4,976,111 shares (2.65%) respectively, while Wang Kai, Wang Jianping, and Li Biyu will no longer hold any shares [2]. Control and Compliance - The share transfer will not lead to a change in the controlling shareholder or actual controllers, with Wang Jianqun remaining the controlling shareholder [2]. - The transaction does not trigger a mandatory tender offer and is not considered a related party transaction, ensuring no adverse impact on the company's operations or minority shareholders [2]. Regulatory Requirements - The share transfer requires compliance confirmation from the Shanghai Stock Exchange and must complete the share transfer registration with the China Securities Depository and Clearing Corporation [2]. - There is uncertainty regarding the completion of the transfer due to potential funding issues from the buyer, Dinglong Qishun [2]. Company Background - Bidet Technology was listed on the Shanghai Stock Exchange on March 1, 2021, with an issuance of 27 million shares at a price of 15.99 yuan per share, raising a total of 432 million yuan [3][4]. - The net proceeds from the IPO amounted to 392 million yuan, allocated for expansion projects, R&D center construction, and working capital [3].